Global Veterinary Vaccine Adjuvants Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Veterinary Vaccine Adjuvants Market
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Due to the COVID-19 pandemic, the global Veterinary Vaccine Adjuvants market size is estimated to be worth US$ 353.4 million in 2022 and is forecast to a readjusted size of US$ 507 million by 2028 with a CAGR of 6.2% during the review period. Fully considering the economic change by this health crisis, Oral accounting for % of the Veterinary Vaccine Adjuvants global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Livestock Vaccines segment is altered to an % CAGR throughout this forecast period.

Europe is the largest region of Veterinary Vaccine Adjuvants, with a market share about 35%. It was followed by North America with 30%. SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma and MVP Laboratories are the top 5 manufacturers of industry, and they had about 70% combined market share.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Oral

Subcutaneous

Intramuscular

Others

Segment by Application

Livestock Vaccines

Companion Animals Vaccines

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Veterinary Vaccine Adjuvants market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

SEPPIC

SDA BIO

Croda International Plc

SPI Pharma

MVP Laboratories

Zhuoyue

Zhiju Bio

TABLE OF CONTENT

1 Study Coverage
1.1 Veterinary Vaccine Adjuvants Product Introduction

1.2 Market by Type

1.2.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Oral

1.2.3 Subcutaneous

1.2.4 Intramuscular

1.2.5 Others

1.3 Market by Application

1.3.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Livestock Vaccines

1.3.3 Companion Animals Vaccines

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Veterinary Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028

2.2 Global Veterinary Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028

2.3 Global Veterinary Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Veterinary Vaccine Adjuvants Sales by Region

2.4.1 Global Veterinary Vaccine Adjuvants Sales by Region (2017-2022)

2.4.2 Global Sales Veterinary Vaccine Adjuvants by Region (2023-2028)

2.5 Global Veterinary Vaccine Adjuvants Revenue by Region

2.5.1 Global Veterinary Vaccine Adjuvants Revenue by Region (2017-2022)

2.5.2 Global Veterinary Vaccine Adjuvants Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Veterinary Vaccine Adjuvants Sales by Manufacturers

3.1.1 Global Top Veterinary Vaccine Adjuvants Manufacturers by Sales (2017-2022)

3.1.2 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Vaccine Adjuvants in 2021

3.2 Global Veterinary Vaccine Adjuvants Revenue by Manufacturers

3.2.1 Global Veterinary Vaccine Adjuvants Revenue by Manufacturers (2017-2022)

3.2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Veterinary Vaccine Adjuvants Revenue in 2021

3.3 Global Veterinary Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Veterinary Vaccine Adjuvants Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Veterinary Vaccine Adjuvants Sales by Type

4.1.1 Global Veterinary Vaccine Adjuvants Historical Sales by Type (2017-2022)

4.1.2 Global Veterinary Vaccine Adjuvants Forecasted Sales by Type (2023-2028)

4.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2017-2028)

4.2 Global Veterinary Vaccine Adjuvants Revenue by Type

4.2.1 Global Veterinary Vaccine Adjuvants Historical Revenue by Type (2017-2022)

4.2.2 Global Veterinary Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)

4.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2017-2028)

4.3 Global Veterinary Vaccine Adjuvants Price by Type

4.3.1 Global Veterinary Vaccine Adjuvants Price by Type (2017-2022)

4.3.2 Global Veterinary Vaccine Adjuvants Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Veterinary Vaccine Adjuvants Sales by Application

5.1.1 Global Veterinary Vaccine Adjuvants Historical Sales by Application (2017-2022)

5.1.2 Global Veterinary Vaccine Adjuvants Forecasted Sales by Application (2023-2028)

5.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2017-2028)

5.2 Global Veterinary Vaccine Adjuvants Revenue by Application

5.2.1 Global Veterinary Vaccine Adjuvants Historical Revenue by Application (2017-2022)

5.2.2 Global Veterinary Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)

5.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2017-2028)

5.3 Global Veterinary Vaccine Adjuvants Price by Application

5.3.1 Global Veterinary Vaccine Adjuvants Price by Application (2017-2022)

5.3.2 Global Veterinary Vaccine Adjuvants Price Forecast by Application (2023-2028)

6 North America

6.1 North America Veterinary Vaccine Adjuvants Market Size by Type

6.1.1 North America Veterinary Vaccine Adjuvants Sales by Type (2017-2028)

6.1.2 North America Veterinary Vaccine Adjuvants Revenue by Type (2017-2028)

6.2 North America Veterinary Vaccine Adjuvants Market Size by Application

6.2.1 North America Veterinary Vaccine Adjuvants Sales by Application (2017-2028)

6.2.2 North America Veterinary Vaccine Adjuvants Revenue by Application (2017-2028)

6.3 North America Veterinary Vaccine Adjuvants Market Size by Country

6.3.1 North America Veterinary Vaccine Adjuvants Sales by Country (2017-2028)

6.3.2 North America Veterinary Vaccine Adjuvants Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Veterinary Vaccine Adjuvants Market Size by Type

7.1.1 Europe Veterinary Vaccine Adjuvants Sales by Type (2017-2028)

7.1.2 Europe Veterinary Vaccine Adjuvants Revenue by Type (2017-2028)

7.2 Europe Veterinary Vaccine Adjuvants Market Size by Application

7.2.1 Europe Veterinary Vaccine Adjuvants Sales by Application (2017-2028)

7.2.2 Europe Veterinary Vaccine Adjuvants Revenue by Application (2017-2028)

7.3 Europe Veterinary Vaccine Adjuvants Market Size by Country

7.3.1 Europe Veterinary Vaccine Adjuvants Sales by Country (2017-2028)

7.3.2 Europe Veterinary Vaccine Adjuvants Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Type

8.1.1 Asia Pacific Veterinary Vaccine Adjuvants Sales by Type (2017-2028)

8.1.2 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Type (2017-2028)

8.2 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Application

8.2.1 Asia Pacific Veterinary Vaccine Adjuvants Sales by Application (2017-2028)

8.2.2 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Application (2017-2028)

8.3 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Region

8.3.1 Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (2017-2028)

8.3.2 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Veterinary Vaccine Adjuvants Market Size by Type

9.1.1 Latin America Veterinary Vaccine Adjuvants Sales by Type (2017-2028)

9.1.2 Latin America Veterinary Vaccine Adjuvants Revenue by Type (2017-2028)

9.2 Latin America Veterinary Vaccine Adjuvants Market Size by Application

9.2.1 Latin America Veterinary Vaccine Adjuvants Sales by Application (2017-2028)

9.2.2 Latin America Veterinary Vaccine Adjuvants Revenue by Application (2017-2028)

9.3 Latin America Veterinary Vaccine Adjuvants Market Size by Country

9.3.1 Latin America Veterinary Vaccine Adjuvants Sales by Country (2017-2028)

9.3.2 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Type

10.1.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2017-2028)

10.1.2 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Type (2017-2028)

10.2 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Application

10.2.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2017-2028)

10.2.2 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Application (2017-2028)

10.3 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country

10.3.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2017-2028)

10.3.2 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 SEPPIC

11.1.1 SEPPIC Corporation Information

11.1.2 SEPPIC Overview

11.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 SEPPIC Recent Developments

11.2 SDA BIO

11.2.1 SDA BIO Corporation Information

11.2.2 SDA BIO Overview

11.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 SDA BIO Recent Developments

11.3 Croda International Plc

11.3.1 Croda International Plc Corporation Information

11.3.2 Croda International Plc Overview

11.3.3 Croda International Plc Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Croda International Plc Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Croda International Plc Recent Developments

11.4 SPI Pharma

11.4.1 SPI Pharma Corporation Information

11.4.2 SPI Pharma Overview

11.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 SPI Pharma Recent Developments

11.5 MVP Laboratories

11.5.1 MVP Laboratories Corporation Information

11.5.2 MVP Laboratories Overview

11.5.3 MVP Laboratories Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 MVP Laboratories Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 MVP Laboratories Recent Developments

11.6 Zhuoyue

11.6.1 Zhuoyue Corporation Information

11.6.2 Zhuoyue Overview

11.6.3 Zhuoyue Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Zhuoyue Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Zhuoyue Recent Developments

11.7 Zhiju Bio

11.7.1 Zhiju Bio Corporation Information

11.7.2 Zhiju Bio Overview

11.7.3 Zhiju Bio Veterinary Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Zhiju Bio Veterinary Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Zhiju Bio Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Veterinary Vaccine Adjuvants Industry Chain Analysis

12.2 Veterinary Vaccine Adjuvants Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Veterinary Vaccine Adjuvants Production Mode & Process

12.4 Veterinary Vaccine Adjuvants Sales and Marketing

12.4.1 Veterinary Vaccine Adjuvants Sales Channels

12.4.2 Veterinary Vaccine Adjuvants Distributors

12.5 Veterinary Vaccine Adjuvants Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Veterinary Vaccine Adjuvants Industry Trends

13.2 Veterinary Vaccine Adjuvants Market Drivers

13.3 Veterinary Vaccine Adjuvants Market Challenges

13.4 Veterinary Vaccine Adjuvants Market Restraints

14 Key Findings in The Global Veterinary Vaccine Adjuvants Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample